Your browser doesn't support javascript.
loading
Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma.
Takakuwa, Teruhito; Ohta, Kensuke; Nakatani, Eiji; Ito, Tomoki; Kaneko, Hitomi; Fuchida, Shin-Ichi; Shimura, Yuji; Yagi, Hideo; Shibayama, Hirohiko; Kanda, Junya; Uchiyama, Hitoji; Kosugi, Satoru; Tanaka, Hirokazu; Kawata, Eri; Uoshima, Nobuhiko; Ishikawa, Jun; Shibano, Masaru; Karasuno, Takahiro; Shindo, Maki; Shimizu, Yoshifumi; Imada, Kazunori; Kanakura, Yuzuru; Kuroda, Junya; Hino, Masayuki; Nomura, Shosaku; Takaori-Kondo, Akifumi; Shimazaki, Chihiro; Matsumura, Itaru.
Afiliación
  • Takakuwa T; Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
  • Ohta K; Department of Hematology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Nakatani E; Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
  • Ito T; Hematology Ohta Clinic, Shinsaibashi, Osaka, Japan.
  • Kaneko H; Division of Statistical Analysis, Research Support Center, Shizuoka General Hospital, Shizuoka, Japan.
  • Fuchida SI; Division of hematology, First Department of Internal Medicine, Kansai Medical University Medical Center, Moriguchi, Japan.
  • Shimura Y; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
  • Yagi H; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Shibayama H; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kanda J; Department of Hematology and Oncology, Nara Prefecture General Medical Center, Nara, Japan.
  • Uchiyama H; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kosugi S; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Tanaka H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Kawata E; Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, Toyonaka, Japan.
  • Uoshima N; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Higashi-osaka, Japan.
  • Ishikawa J; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Shibano M; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Karasuno T; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
  • Shindo M; Department of Hematology, Sakai City Medical Center, Sakai, Japan.
  • Shimizu Y; Department of Hematology, Rinku General Medical Center, Izumisano, Japan.
  • Imada K; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kanakura Y; Department of Hematology, Takarazuka Municipal Hospital, Takarazuka, Japan.
  • Kuroda J; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
  • Hino M; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Nomura S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Takaori-Kondo A; Department of Hematology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Shimazaki C; Division of hematology, First Department of Internal Medicine, Kansai Medical University Medical Center, Moriguchi, Japan.
  • Matsumura I; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hematol Oncol ; 39(3): 349-357, 2021 Aug.
Article en En | MEDLINE | ID: mdl-33724498
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bases de Datos Factuales / Lenalidomida / Mieloma Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bases de Datos Factuales / Lenalidomida / Mieloma Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido